⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 1, 1933Journal of Clinical InvestigationOpen Access

The Action of Phlorizin on the Excretion of Glucose, Xylose, Sucrose, Creatinine and Urea by Man

Herbert Chasis Norman Jolliffe Homer W. Smith

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Although phlorizin has been used mostly in the lower animals, its administration to man is

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chasis et al. (1933) studied this question.

synapsesocial.com/papers/6a711bf7ac440176ef29c9c8 https://doi.org/10.1172/jci100559

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Endothelial neo-antigen expression initiates CD8⁺ T cell–driven CNS vasculitis amplified by peripheral immune challengeJournal of Clinical Investigation · Tue,
2FAP-targeting CAR T cells with constitutive IL-10 expression reduce kidney fibrosis in miceJournal of Clinical Investigation · Tue,
3Jet-injected combinational adjuvants potentiate naked mRNA vaccines for protection against respiratory viral infections in miceJournal of Clinical Investigation · Tue,
4Astrocytic glutamate transporter loss drives chemoreflex hyperactivity and cardiorespiratory dysfunction in a heart failure modelJournal of Clinical Investigation · Tue,
5Restoration of full length filamin C is sufficient to prevent FLNC deficient cardiomyopathy in miceJournal of Clinical Investigation · Tue,

More from Journal of Clinical Investigation

Edited HSPCs rescue frataxin deficiency and inflammation-driven multisystemic pathology in Friedreich’s ataxia miceWed,
Interferon-λ inhibits immunopathology and boosts T cell–mediated immunity in a mouse model of mucosal viral infectionWed,
ISG15+ Müller glial subtype contributes to early blood–retinal barrier breakdown in diabetic retinopathyWed,
Modeling human neurodegeneration with iPSCs: opportunities, limitations, and the challenge of agingWed,
Next-generation CDK inhibitors in HR+/HER2– breast cancerWed,